uridine-derivative nucleoside virus replication inhibitors (Universite d'Orleans/INSERM)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameuridine-derivative nucleoside virus replication inhibitors (Universite d'Orleans/INSERM)
Drug Alias NameNS5B polymerase inhibitor (Universite d'Orleans/INSERM)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversite d'Orleans
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInserm TransfertUniversite d'OrleansInserm
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A